Androzene Male Enhancement Product Ad Claims Fail To Withstand NAD Review
This article was originally published in The Rose Sheet
Executive Summary
Health Club Diet discontinues challenged claims for Androzene male enhancement supplement after NAD criticizes firm for relying on studies on ingredients, not the product. Council for Responsible Nutrition challenged claims as stating an indication for erectile dysfunction drug.
You may also be interested in...
CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising
The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.
TummyZen Firm Appeals After Heartburn Claims Don't Settle Well In NAD Review
Eli Consumer Healthcare is latest supplement marketer National Advertising Division has advised that tests of separate ingredients do not support claims for a whole product. Following NADs review of TummyZen claims on challenge by Tums firm GlaxoSmithKline, Eli Consumer appeals NAD's recommendations to discontinue claims that its supplement “stops acid production,” is “acid inhibiting,” “halts the secretion of chloride ions in your parietal cells to regulate the release of acid into your stomach,” “supports stomach lining” and is “long lasting."
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.